26 related articles for article (PubMed ID: 1685738)
1. Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma.
Farag HH; Wu WM; Barros MD; Somogyi G; Prokai L; Bodor N
Drug Des Discov; 1997 Aug; 15(2):117-30. PubMed ID: 9342554
[TBL] [Abstract][Full Text] [Related]
2. L-653,328: an ocular hypotensive agent with modest beta receptor blocking activity.
Sugrue MF; Gautheron P; Grove J; Mallorga P; Viader MP; Baldwin JJ; Ponticello GS; Varga SL
Invest Ophthalmol Vis Sci; 1988 May; 29(5):776-84. PubMed ID: 2896641
[TBL] [Abstract][Full Text] [Related]
3. Effect of betaxolol on primary open-angle glaucoma and normal-tension glaucoma patients.
Saccà SC; Macrì A; Rolando M; Ciurlo G
J Ocul Pharmacol Ther; 1998 Jun; 14(3):191-201. PubMed ID: 9671427
[TBL] [Abstract][Full Text] [Related]
4. [Nanocapsules of beta-blocking agents: a new drug carrier in ophthalmology. Application to medical treatment of glaucoma in rabbits].
Marchal-Heussler L; Sirbat D; Hoffman M; Maincent P
J Fr Ophtalmol; 1991; 14(6-7):371-5. PubMed ID: 1685738
[TBL] [Abstract][Full Text] [Related]
5. Comparison of ophthalmic beta-blocking agents.
Lesar TS
Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
[TBL] [Abstract][Full Text] [Related]
6. Are there any benefits of Betoptic S (betaxolol HCl ophthalmic suspension) over other beta-blockers in the treatment of glaucoma?
Yarangümeli A; Kural G
Expert Opin Pharmacother; 2004 May; 5(5):1071-81. PubMed ID: 15155109
[TBL] [Abstract][Full Text] [Related]
7. Ocular betaxolol. A review of its pharmacological properties, and therapeutic efficacy in glaucoma and ocular hypertension.
Buckley MM; Goa KL; Clissold SP
Drugs; 1990 Jul; 40(1):75-90. PubMed ID: 2202584
[TBL] [Abstract][Full Text] [Related]
8. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
Greenfield DS; Liebmann JM; Ritch R
J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
[TBL] [Abstract][Full Text] [Related]
9. Designing safer ophthalmic drugs by soft drug approaches.
Bodor N
J Ocul Pharmacol; 1994; 10(1):3-15. PubMed ID: 7911503
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
